Skip to main content
Clinical Trials/NCT03347851
NCT03347851
Completed
Not Applicable

Investigation of Post-surgical Aortic Hemodynamics After Aortic Valve Replacement

CryoLife, Inc.1 site in 1 country20 target enrollmentOctober 26, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Valve Heart Disease
Sponsor
CryoLife, Inc.
Enrollment
20
Locations
1
Primary Endpoint
Downstream flow patterns (helicity and vorticity)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this pilot study is to obtain both near valve and downstream flow characteristics, using 3D transthoracic echocardiography and 4D flow MRI respectively, in an existing patient population at Northwestern Memorial Hospital, to determine the hinge washout characteristics and downstream flow patterns of the On-X valve and compared to competing designs.

Detailed Description

Prospective, concurrent 4D flow Magnetic Resonance Imaging (MRI) and echocardiography of On-X and St Jude Medical (SJM) Masters HP or Carbomedics Carbo-seal or Carbo-seal Valsalva aortic valve replacement (AVR) patients will be performed. Echocardiography analysis will include: valve function (opening angle), pressure gradients, and degree of valve washout. MRI analysis will focus on downstream flow patterns (helicity and vorticity), energy loss, pressure recovery, and measurement of wall shear stress in the anastomosis regions.

Registry
clinicaltrials.gov
Start Date
October 26, 2017
End Date
June 1, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male and female subjects 18-89 years of age
  • Patients with aortic valve disease who within the last five years underwent AVR using the On-X aortic valve, SJM Masters HP, or Carbomedics aortic valves.

Exclusion Criteria

  • Patients contraindicated against MRI
  • Patients with pacemakers, cochlear (in the ear) implants, or aneurysm clips or patients who have worked with metal
  • Patients unwilling or unable to give written informed consent
  • Pregnant women
  • Prisoners
  • Patients with an Effective Orifice Area index (EOAi) \<0.85 cm2/m2

Outcomes

Primary Outcomes

Downstream flow patterns (helicity and vorticity)

Time Frame: 3 months

MRI data analysis; Helicity and vorticity graded (1-3) by blinded reviewers.

Hinge washout

Time Frame: 3 months

MRI data analysis; Yes/No

Wall shear stress (WSS)

Time Frame: 3 months

MRI data analysis; WSS, the tangential force exerted by blood flow on the vessel wall, measured in the anastomosis regions

Energy loss

Time Frame: 3 months

MRI data analysis; Irreversible energy loss quantified.Efforts will include the quantification of turbulent kinetic energy. This is representative of permanent pressure loss.

Secondary Outcomes

  • Ejection Fraction (%)(3 months)
  • Normalized ESV (mL/m^2)(3 months)
  • Mean transvalvular pressure gradient (mmHg)(3 months)
  • Primary ESV (mL)(3 months)
  • Mean velocity (m/s)(3 months)
  • Normalized EDV (ml/m^2)(3 months)
  • Peak transvalvular pressure gradient (mmHg)(3 months)
  • Effective Orifice Area (EOA)(3 months)
  • Primary EDV (ml)(3 months)
  • Peak Velocity (m/s)(3 months)
  • Effective Orifice Area index (EOAi)(3 months)

Study Sites (1)

Loading locations...

Similar Trials